Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Neptune shifts operations

This article was originally published in The Tan Sheet

Executive Summary

Neptune Technologies & Bioresources transfers the license for its cardiovascular application portfolio to operating subsidiary Acasti Pharma to develop active pharmaceutical ingredients for products in the Rx, OTC and medical food markets, the firm announces Aug. 21. Under the arrangement, Quebec-based Acasti will research, develop and market the APIs, with the goal of entering strategic pharmaceutical partnerships. Neptune announced a deal with Yoplait in June 2007 to provide its Neptune Krill Oil - a composition with proprietary omega-3 phospholipids - for use in functional yogurt products (1"The Tan Sheet" July 2, 2007, In Brief)

You may also be interested in...



Neptune blasts off with Bayer

The Canadian maker of omega-3 phospholipid ingredients announces Bayer Healthcare will commercialize its proprietary products in the U.S. Neptune Technologies & Bioresources credits its "complete portfolio of scientific data, intellectual property and regulatory approvals" with paving the way for the partnership. The firm said June 4 it expects Bayer will help broaden consumer awareness of its products, including Neptune Krill Oil and Advantage NKO dietary supplement. Neptune's strategy is "to penetrate world nutraceutical and pharmaceutical markets" through collaborations with global partners, said Henri Harland, president and CEO for the Laval, Quebec-based company. Neptune previously teamed with Yoplait on functional yogurts and shifted the license for its cardiovascular application portfolio to subsidiary Acasti Pharma (1"The Tan Sheet" Sept. 1, 2008, In Brief)

KrillYoplait

Neptune Technologies & Bioressources announces June 19 a partnership with Yoplait to develop new functional dairy products for worldwide commercialization. Yoplait will launch dairy products containing Neptune Krill Oil in "strategically chosen countries followed by a worldwide rollout," Neptune says. The firm will supply Yoplait with NKO and will receive an upfront fee as well as milestone payments and distribution royalties, Neptune states. This is not Yoplait's first venture into functional yogurt; in January Yoplait announced it added Martek's life'sDHA to its kids line (1"The Tan Sheet" Jan. 22, 2007, In Brief)...

Belgium Outlaws OTC Cough And Cold Combination Drugs

Safety concerns prompt Belgium's drug regulator to order all OTC fixed combination products for coughs and colds removed from shelves.

Topics

UsernamePublicRestriction

Register

PS102056

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel